ABSTRACT Two hundred patients aged 
The symptomatic and haemodynamic improvements brought about by commissurotomy in rheumatic mitral stenosis have been well documented.' 2 The emphasis in current publications is on open heart surgery in mitral stenosis and the relatively simple method of closed mitral valvotomy tends to be overlooked.24 This may be unfortunate because most rheumatic mitral valve disease occurs in developing countries where modem expensive facilities for cardiological investigation and open heart surgery are not usually available.5`7 There is, however, evidence of some recent revival of interest in closed mitral valvotomy and confirmation of its value in the long term relief of symptoms.8 9 A recent report of the outcome in over 600 patients attempted to identify clinical predictors of survival.'O Nevertheless, there is still considerable disagreement about the long term effects of mitral valvotomy. " -13 The present study aimed to identify specific features of mitral stenosis that would predict long term survival in patients undergoing closed valvotomy. We have analysed data on 200 consecutive patients who had been treated in this way 22-27 years previously.
Methods

SELECTION AND FOLLOW UP OF PATIENTS
We studied records of 218 consecutive patients, aged 17-40 years, who underwent closed mitral valvotomy in Liverpool from January 1955 to December 1960. The eight patients who had had a previous valvotomy elsewhere and a further 10 suffering from systemic illnesses (for example, diabetes mellitus) were excluded. The resulting sample consisted of 200 patients, 42 men and 158 women.
The patients had initially been referred to Liverpool from a wide area covering North Wales, Merseyside, and Lancashire. Data were collected by examining case records, operation notes, personal records of the cardiologists, and communications from referring physicians and family practitioners obtained in response to a simple postal questionnaire.
A second closed valvotomy was done on those patients who showed progressive deterioration in symptoms-for example, paroxysmal nocturnal dyspnoea, palpitations on exertion, and congestive cardiac failure (New York Heart Association (NYHA) 401 402 with g-l degrees of freedom (g equals the number of subgroups in each variable).
The independent significant variables thus obtained were combined to observe their predictive value on long term survival. This was done by logistic analysis with SPSSX'7 on the assumption of additivity of effects on log odds scale-that is, risk factors multiplicative on odds scale. This assumption gave an acceptable goodness of fit of the observed survival data-namely, 2 (X2 = 26.8, 26 df, NS). The 5% level of probability was taken as significant.
Results
POPULATION AND VARIABLES
Two hundred patients were entered in the study. The mean age at operation was 29 (range 17-40) years. The female to male ratio was 4:1.
The duration of symptoms before valvotomy (palpitations, paroxysmal nocturnal dyspnoea, and dyspnoea on exertion) was five years or less in 100 patients (50%), > 5-10 years in 48 (24%), > 10-15 years in 23 (11.5%), > 15-20 years in eight (4%); and more than 20 years in six (3%).
One hundred and thirty patients (65%) had sinus rhythm, 65 (33%) atrial fibrillation, and four (2%) variable rhythm. In one patient the preoperative electrocardiogram was unavailable. A systolic pulmonary artery pressure of less than 50 mm Hg was classified as "mild" pulmonary hypertension (80 patients, 40%), 50-79 mm Hg as "moderate" (78 patients, 39%), and 80 mm Hg or more as "severe" (28 patients, 14%).
Seventy one patients (35%) had congestive cardiac failure at the time of operation (NYHA criteria classes III and IV). In 28 (14%) congestive cardiac failure persisted after valvotomy; 38 patients (19%) developed it after operation; 37 patients (19%) did not suffer from it at any time. In the remaining 54 patients (27%), although none was in heart failure before valvotomy, the functional class was not specifically recorded at the last follow up examination.
Twenty seven patients (13%) had had at least one significant systemic embolic event before operation and 20 (10%) developed embolism during the follow up period. One patient developed emboli both before Preoperative clinical predictors of long term survival in mitral stenosis and after valvotomy. Seventeen out of 47 patients with emboli were in sinus rhythm; 133 patients (66%) did not suffer from embolic episodes. For 19 patients (10%) lost to follow up the history relating to embolism was uncertain.
Forty eight patients (27%) had appreciable mitral regurgitation, 30 (15%) had associated aortic stenosis, four had tricupsid stenosis, and four had multiple valves affected. One hundred and fourteen patients (57%) had pure mitral stenosis without clinical evidence of appreciable regurgitation. The degree of calcification was recorded as nil to minimal in 148 patients (74%) and moderate to severe in 47 patients (27%). This information was not available for five patients.
The extent of valve fibrosis at the time of operation was recorded as "mild" (46 patients, 23%), "moderate" (40 patients, 20%) or "severe" (110 patients, 55%). Records were not available for four patients.
One hundred and six patients (53%) were operated on with Tubb's dilator and 68 (34%) by finger fracture of the fused valve. In the remaining 26 patients (13%) other methods were used and 14 (7%) of them had mitral and aortic valvotomies performed at the same time.
Long term anticoagulation was given to 48 patients (24%); 66 patients (33%) did not receive any anticoagulation. Of the remaining 86 patients (43%), some had received anticoagulation for two years only20 and others had received either none at all or only intermittent anticoagulation and were excluded from this part of the analysis.
Twenty seven patients (14%) had a second valvotomy-10 within the first five years, 10 within the next five years, four 10 to 15 years, one between 15 to 20 years, and two more than 25 years after operation. Thirty two patients (16%) had mitral valve replacements-18 10-19 years and 14 more than 20 years after operation.
At the time of the last follow up examination or death, 107 patients (53%) had atrial fibrillation, 81 (40%) sinus rhythm, and seven (3%) other rhythms. The ECGs of five patients were not available.
ANALYSIS OF SURVIVAL
Follow up One hundred and ten patients were followed up, either to the present day or to the time of death. Of the original group, 20 patients had been lost by five years and 84 by 10 years. Thereafter only a further six patients were lost. The high rate of fallout from the study from 5 to 10 years is partly explained by the reorganisation of the referral system in the National Health Service and the very wide area covered by the Liverpool hospitals providing a regional cardiological service. We sinus rhythm, the case for offering anticoagulation treatment to all patients with mitral stenosis, inrrespective of rhythm, history of embolic events, or cardiac failure, would appear to be strengthened.
Our observations that preoperative congestive cardiac failure and severe pulmonary arterial hypertension are markers of poor prognosis challenges the teaching2" that mitral valve surgery should be undertaken only if medical treatment fails to control symptoms. Our results support the view that early intervention is desirable. 25 26 As regards actual operative technique, the study supports the current preference for a transventricular approach with a mechanical dilator27 rather than other methods. 28 In contrast to the findings of Cummerford et al,'3 our results suggest that extent of fibrosis of the mitral valve apparatus has no bearing on long term survival and that the high level of pulmonary artery pressure is indeed associated with a poor prognosis.
We conclude that closed mitral valvotomy by the transventricular approach with a mechanical dilator may be associated with an excellent long term outcome. Most of the predictors of survival after operations are available from clinical examination, the chest radiograph, and the ECG. Although open heart surgery has largely displaced closed mitral valvotomy, the latter still has a part to play in the management of mitral stenosis, especially in countries with limited resources. 
